# Eva Garland Consulting

> Eva Garland Consulting \(EGC\) is an Inc\. 5000 fastest growing consulting firm that assists scientists and entrepreneurs in securing and managing resources to accelerate development of their innovative technologies\.

Generated by Yoast SEO v28.6, this is an llms.txt file, meant for consumption by LLMs.

## Pages
- [Blogs \& Webcasts](https://www.evagarland.com/resources/blogs-webcasts/)
- [Homepage](https://www.evagarland.com/)
- [Resources](https://www.evagarland.com/resources/)
- [Our Impact](https://www.evagarland.com/our-impact/)
- [Accounting \& Compliance](https://www.evagarland.com/accounting/)

## Posts
- [SBIR Reauthorization](https://www.evagarland.com/sbir-reauthorization-where-we-stand/): By broadening the set of agencies, programs, and partnerships you consider, you can diversify funding sources, reduce vulnerability to individual program delays, and uncover new opportunities that align with your scientific development and fundraising needs\. 
- [SBIR/STTR Accounting \& Compliance Essentials](https://www.evagarland.com/sbir-sttr-accounting-essentials/)
- [How to Actually Get Paid on Your SBIR/STTR Award](https://www.evagarland.com/how-to-get-paid-on-sbir-award/): Learn how the NIH JIT process works, what documents are required, and how to respond to a JIT request\. Expert guidance for SBIR/STTR applicants\.
- [September 2026 Newsletter](https://mailchi.mp/evagarland/september2026newsletter/): This month, EGC spotlights ScitoVation’s $3\.2M\+ in NIH funding to advance a predictive, human\-relevant approach to evaluating chemical safety during pregnancy\. We also highlight an upcoming webinar on SBIR/STTR accounting and compliance essentials, share a recording covering key 2026 NIH solicitation updates, and feature new funding opportunities from ARPA\-H, BARDA, CDMRP, DoW, NIH, NSF, and private foundations\.
- [Winning NIH SBIR/STTR Grants in 2026](https://www.evagarland.com/winning-nih-grants-in-2026/)

## Showcase
- [WinSanTor](https://www.evagarland.com/showcase/winsantor/): Over $40M in Funding Propels Neuropathy Therapy to Phase 3 Clinical Trials\.\.\.
- [Pascall Systems](https://www.evagarland.com/showcase/pascall-systems/): Pascall Systems Secures More Than $13\.6 Million from NIH to Personalize Anesthesia and Improve Surgical Outcomes
- [TARGAN](https://www.evagarland.com/showcase/targan/): From NSF SBIR Award to Merck Acquisition: TARGAN's Journey to Improving Animal Health
- [Thymmune Therapeutics](https://www.evagarland.com/showcase/thymmune-therapeutics/): $58M ARPA\-H Award Advances Next\-Generation Thymic Cell Therapies\.\.\. 
- [Transmural Systems](https://www.evagarland.com/showcase/transmural-systems/): $36M\+ Funding Accelerates Innovative Cardiology Device Development\.\.\. 

## Optional
- [Sitemap index](https://www.evagarland.com/sitemap_index.xml)